Preclinical development of an efficient and safe gene editing platform for the treatment of Wiskott Aldrich Syndrome

被引：0
|
作者：
Naseem, A. [1 ]
Turchiano, G. [1 ]
Rai, R. [1 ]
Vetharoy, W. [1 ]
Whittaker, T. E. [1 ]
Thrasher, A. J. [1 ,2 ]
Cavazza, A.
机构：
[1] UCL Inst Child Hlth, London, England
[2] NIHR Great Ormond St Hosp, Biomed Res Ctr, London, England
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 23-24期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P667
引用
收藏
页码：A202 / A203
页数：2
相关论文
共 50 条
  • [1] Preclinical studies for a hematopoietic stem cell gene editing platform to treat Wiskott-Aldrich Syndrome.
    Naseem, A.
    Vetharoy, W.
    Rai, R.
    Whittaker, T. E.
    Turchiano, G.
    Thrasher, A. J.
    Cavazza, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A72 - A72
  • [2] Preclinical Safety and Feasibility Study of a CRISPR/Cas9 Gene Editing Platform to Treat Wiskott Aldrich Syndrome
    Naseem, Asma
    Rai, Rajeev
    Turchiano, Giandomenico
    Whittaker, Thomas
    Thrasher, Adrian J.
    Cavazza, Alessia
    MOLECULAR THERAPY, 2022, 30 (04) : 34 - 34
  • [3] Hematopoietic Stem Cell Gene Editing for the Treatment of Wiskott-Aldrich Syndrome
    Cavazza, Alessia
    Rai, Rajeev
    Santilli, Giorgia
    Thrasher, Adrian J.
    MOLECULAR THERAPY, 2018, 26 (05) : 3 - 4
  • [4] Haematopoietic stem cell gene editing for the treatment of Wiskott-Aldrich syndrome
    Rai, R.
    Santilli, G.
    Thrasher, A. J.
    Cavazza, A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A106 - A106
  • [5] CRISPR/Cas9-mediated gene editing for treatment of the Wiskott-Aldrich Syndrome
    Pille, M.
    Avila, J. M.
    Park, S. H.
    Xue, H.
    Haerynck, F.
    Kerre, T.
    Bao, G.
    Vandekerckhove, B.
    Davis, B. R.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A62 - A63
  • [6] Development of lentiviral gene therapy for Wiskott Aldrich syndrome
    Galy, Anne
    Roncarolo, Maria-Grazia
    Thrasher, Adrian J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (02) : 181 - 190
  • [7] Comparison of genome editing tools for Wiskott-Aldrich syndrome gene therapy
    Gutierrez-Guerreo, A.
    Sanchez-Hernandez, S.
    Galvani, G.
    Pinedo-Gomez, J.
    Toscano, M. G.
    Cobo, M.
    Gregory, P. D.
    Holmes, M. C.
    Benabdellah, K.
    Martin, F.
    HUMAN GENE THERAPY, 2016, 27 (11) : A130 - A131
  • [8] Targeted Gene Correction for the Treatment of Wiskott-Aldrich Syndrome
    Cavazza, Alessia
    Rai, Rajeev
    Zinicola, Marta
    Rivers, Elizabeth
    Santilli, Giorgia
    Thrasher, Adrian J.
    MOLECULAR THERAPY, 2017, 25 (05) : 91 - 91
  • [9] Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome
    Pille, Melissa
    Avila, John M.
    Park, So Hyun
    Le, Cuong Q.
    Xue, Haipeng
    Haerynck, Filomeen
    Saxena, Lavanya
    Lee, Ciaran
    Shpall, Elizabeth J.
    Bao, Gang
    Vandekerckhove, Bart
    Davis, Brian R.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [10] Genome editing: An alternative to retroviral vectors for Wiskott-Aldrich Syndrome (WAS) Gene Therapy?
    Martin, F.
    Gutierrez-Guerrero, A.
    Sanchez, S.
    Galvani, G.
    Benabdellah, K.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (03): : 281 - 289
12345